Skip to main content
NIH funding notice PAR-18-661

Pathway and Target Identification for Alzhiemers Disease Related Dementias (ADRDs) (U01 Clinical Trial Not Allowed)

Closed on April 16, 2018.

Posted
February 14, 2018
Close date
April 16, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,348,579 in first-year total cost, median $1,348,579.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-J (21)]1

Most frequent institutions

  1. MASSACHUSETTS INSTITUTE OF TECHNOLOGY1
Competing awards under PAR-18-661 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Single-cell transcriptional and epigenomic dissection of Alzheimer's Disease and Related Dementias1U01NS110453-01KELLIS, MANOLISTSAI, LI-HUEIMASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA$1,348,579ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-661: Pathway and Target Identification for Alzhiemers Disease Related Dementias (ADRDs) (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience